Abstract |
Immune checkpoint inhibitors (ICIs) targeting programmed cell death-1 (PD-1) and programmed cell death- ligand 1 (PD-L1) have markedly improved the prognosis of many patients with advanced non-small cell lung cancer (NSCLC). However, the relationship between the patient's nutritional/immunologic status and the outcomes of ICI treatment remains unclear. In previous retrospective studies, we reported that the controlling nutritional status (CONUT) score, skeletal muscle area, and neutrophil-to-lymphocyte ratio were independent predictors of the response of NSCLC patients to anti-PD-1 drugs. The aim of this prospective multi-center study is to investigate the clinical impact of pre-treatment nutritional/immunologic indices and early post-treatment changes in the indices on treatment outcomes in advanced NSCLC. The main inclusion criteria are: (1) stage IV NSCLC, or stage III NSCLC not applicable for definitive chemoradiotherapy; (2) treatment with ICIs (monotherapy or combined with chemotherapy) as first-line therapy; and (3) available data on PD-L1 expression on tumor cells. A total of 300 patients will be enrolled prospectively. Enrollment will begin in 2020 and the final analyses will be completed by 2025.
|
Authors | Shinkichi Takamori, Taro Ohba, Mototsugu Shimokawa, Taichi Matsubara, Naoki Haratake, Naoko Miura, Ryo Toyozawa, Masafumi Yamaguchi, Takashi Seto, Mitsuhiro Takenoyama |
Journal | PloS one
(PLoS One)
Vol. 16
Issue 10
Pg. e0258616
( 2021)
ISSN: 1932-6203 [Electronic] United States |
PMID | 34679113
(Publication Type: Journal Article, Multicenter Study, Observational Study, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Albumins
- B7-H1 Antigen
- Biomarkers
- CD274 protein, human
- Immune Checkpoint Inhibitors
- Cholesterol
|
Topics |
- Albumins
(metabolism)
- B7-H1 Antigen
(metabolism)
- Biomarkers
(metabolism)
- Carcinoma, Non-Small-Cell Lung
(drug therapy, metabolism, pathology)
- Cholesterol
(metabolism)
- Humans
- Immune Checkpoint Inhibitors
(pharmacology, therapeutic use)
- Lung Neoplasms
(drug therapy, metabolism, pathology)
- Lymphocyte Count
- Male
- Neoplasm Staging
- Nutritional Status
- Prognosis
- Prospective Studies
- Treatment Outcome
|